Incretin-based therapies for the treatment of obesity-related diseases

Incretin-based therapies for the treatment of obesity-related diseases

Abstract Obesity-related disability-adjusted life years (DALYs) are expected to increase by approximately 40% from 2020 to 2030. DALYs and mortality related to obesity are the consequence of multiple comorbidities such as cardiovascular (i.e., heart failure) and metabolic diseases (i.e. type 2 diabe...

Full description

Saved in:
Bibliographic Details
Main Authors: Irene Caruso, Angelo Cignarelli, Gian Pio Sorice, Sebastio Perrini, Francesco Giorgino
Format: Article
Language:English
Published: Nature Portfolio 2024-11-01
Series:npj Metabolic Health and Disease
Online Access:https://doi.org/10.1038/s44324-024-00030-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items